Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aobiome
AddedFeb 15, 2024
UpdatedJun 18, 2026
Aobiome

Aobiome

Series C

AOBiome: A U.S. biotech firm innovating health through ammonia-oxidizing bacteria-based products.

HQ
Cambridge, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

AOBiome is a Boston-based biotech company founded with the mission to transform human health by restoring ammonia-oxidizing bacteria (AOB) to the skin. The company's vision is to leverage this novel class of therapeutics to improve skin health, hypertension, and other systemic conditions. AOBiome focuses on developing live topical biotherapeutics specifically designed to treat a broad range of inflammatory skin disorders, aiming to restore immune functionality that has been compromised by modern living.

Notable figures affiliated with AOBiome include its team of leading scientists and researchers in the field of microbiome science. The company has attracted significant investment from prominent biotech investors, enabling it to advance its innovative treatments through late-stage clinical trials. AOBiome's key achievements include the development of a proprietary strain of AOB and the successful demonstration of its efficacy in improving skin health. The overall impact of AOBiome's work lies in its potential to revolutionize the treatment of inflammatory skin conditions and other related health issues by reintroducing beneficial bacteria to the human microbiome.

Aobiome - Similar Companies

Naked Biome logo

Naked Biome

DermBiont logo

DermBiont

dermbiont.com

Petri Bio logo

Petri Bio

petribio.com

Solarea Bio logo

Solarea Bio

solareabio.com

Holobiome logo

Holobiome

holobiome.org

MatriSys Bioscience logo

MatriSys Bioscience

matrisysbio.com

Omni Biosciences logo

Omni Biosciences

MarvelBiome logo

MarvelBiome

marvelbiome.com

AgBiome logo

AgBiome

agbiome.com

GenieBiome logo

GenieBiome

Aibios logo

Aibios

aibios.com

Entrinsic Bioscience logo

Entrinsic Bioscience

Luca Biologics logo

Luca Biologics

seedhealth.com

Phyla logo

Phyla

phylabiotics.com

PhagePro logo

PhagePro

phageproinc.com

Aobiome - Quick Facts

Who are Aobiome's competitors?

Companies similar to Aobiome include Naked Biome, DermBiont, Petri Bio and Solarea Bio.

When was Aobiome founded?

Aobiome was founded in 2013.

Where is Aobiome's headquarters located?

Aobiome's headquarters is located in Cambridge, MA, US.

When was Aobiome's last funding round?

Aobiome's most recent funding round was for $30M (USD) in January 2017.

How much has Aobiome raised to-date?

As of Jan 5, 2017, Aobiome has raised a total of $38.7M (USD).

How many employees does Aobiome have?

Aobiome has 15 employees as of Feb 5, 2024.

Aobiome - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotherapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified